Issuer disclosure record

$KERX

Company name unavailable

Transactions involving this ticker in readable 2017 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.

Purchases

Sales

Filers

Reports

Transaction history

Who disclosed trading $KERX?

Open in trade feed →

purchaseRep. Debbie Wasserman SchultzFL-23

$KERXKeryx Biopharmaceuticals, Inc. (KERX)

Rep. Debbie Wasserman Schultz's filing reports that a dependent child account purchased · $1,001 – $15,000

View transaction source status →

Traded Feb 10, 2017Notified Feb 11, 2017Filed Feb 15, 20175 days to file

Owner: Dependent childOriginal filing ↗